Atomo Diagnostics Past Earnings Performance
We're still processing the latest earnings report of this company
Past criteria checks 0/6
Atomo Diagnostics's earnings have been declining at an average annual rate of -4.6%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 5.7% per year.
Key information
-4.6%
Earnings growth rate
11.0%
EPS growth rate
| Medical Equipment Industry Growth | 5.8% |
| Revenue growth rate | 5.7% |
| Return on equity | -67.9% |
| Net Margin | -167.6% |
| Next Earnings Update | 30 Jan 2025 |
Recent past performance updates
Recent updates
We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth
Jul 05
We Think Atomo Diagnostics (ASX:AT1) Can Afford To Drive Business Growth
Oct 10Is Atomo Diagnostics (ASX:AT1) In A Good Position To Invest In Growth?
Jun 10We're Not Worried About Atomo Diagnostics' (ASX:AT1) Cash Burn
Dec 06Atomo Diagnostics Limited (ASX:AT1) Shares Could Be 50% Below Their Intrinsic Value Estimate
Nov 01We're Interested To See How Atomo Diagnostics (ASX:AT1) Uses Its Cash Hoard To Grow
Jul 19Market Sentiment Around Loss-Making Atomo Diagnostics Limited (ASX:AT1)
Feb 26Atomo Diagnostics (ASX:AT1) Is In A Strong Position To Grow Its Business
Jan 22Here's What Atomo Diagnostics Limited's (ASX:AT1) Shareholder Ownership Structure Looks Like
Dec 18
When Can We Expect A Profit From Atomo Diagnostics Limited (ASX:AT1)?
Jul 16Revenue & Expenses Breakdown
How Atomo Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 4 | -7 | 5 | 0 |
| 31 Mar 24 | 4 | -7 | 6 | 0 |
| 31 Dec 23 | 3 | -7 | 6 | 0 |
| 30 Sep 23 | 3 | -9 | 6 | 0 |
| 30 Jun 23 | 3 | -10 | 7 | 1 |
| 31 Mar 23 | 5 | -9 | 7 | 1 |
| 31 Dec 22 | 8 | -9 | 7 | 1 |
| 30 Sep 22 | 10 | -7 | 7 | 1 |
| 30 Jun 22 | 12 | -6 | 7 | 1 |
| 31 Mar 22 | 10 | -6 | 7 | 1 |
| 31 Dec 21 | 7 | -6 | 7 | 1 |
| 30 Sep 21 | 7 | -6 | 7 | 1 |
| 30 Jun 21 | 7 | -6 | 6 | 1 |
| 31 Mar 21 | 8 | -8 | 6 | 1 |
| 31 Dec 20 | 9 | -10 | 6 | 1 |
| 30 Sep 20 | 7 | -9 | 5 | 1 |
| 30 Jun 20 | 5 | -9 | 4 | 1 |
| 31 Mar 20 | 3 | -7 | 4 | 1 |
| 31 Dec 19 | 1 | -5 | 3 | 1 |
| 30 Sep 19 | 1 | -5 | 3 | 1 |
| 30 Jun 19 | 1 | -5 | 3 | 1 |
| 30 Jun 18 | 0 | -5 | 2 | 3 |
| 30 Jun 17 | 0 | -5 | 2 | 3 |
Quality Earnings: AT1 is currently unprofitable.
Growing Profit Margin: AT1 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AT1 is unprofitable, and losses have increased over the past 5 years at a rate of 4.6% per year.
Accelerating Growth: Unable to compare AT1's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AT1 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.7%).
Return on Equity
High ROE: AT1 has a negative Return on Equity (-67.9%), as it is currently unprofitable.